Ultrathin Struts Drug-Eluting Stents: A State-of-the-Art Review

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial

(2022) Robbert de Winter de Winter et al.   EuroIntervention

Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex

(2021) Chao Gao et al.   Circulation-Cardiovascular Interventions

Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials

(2021) Thomas Pilgrim et al.   AMERICAN HEART JOURNAL

Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials

(2021) Mahesh V Madhavan et al.   EUROPEAN HEART JOURNAL

Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations

(2020) Luca Gaido et al.   Circulation-Cardiovascular Interventions

10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents

(2020) Sebastian Kufner et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial

(2019) Azfar Zaman et al.   LANCET

Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study)

(2019) Fabrizio D'Ascenzo et al.   AMERICAN JOURNAL OF CARDIOLOGY

Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial

(2019) Lisette Okkels Jensen MD DMSci et al.   AMERICAN HEART JOURNAL

Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials

(2019) Raffaele Piccolo et al.   LANCET

Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels

(2019) Rosaly A. Buiten et al.   JAMA Cardiology

Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus

(2019) Ron Waksman et al.   AMERICAN JOURNAL OF CARDIOLOGY

Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

(2019) Juan F. Iglesias et al.   Circulation-Cardiovascular Interventions

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents

(2019) Rosaly A. Buiten et al.   JACC-Cardiovascular Interventions

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial

(2019) Juan F Iglesias et al.   LANCET

Prospective evaluation of an ultrathin strut biodegradable polymer-coated sirolimus-eluting stent: 12 months’ results from the S-FLEX UK registry

(2019) Anirban Choudhury et al.   BMJ Open

Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes

(2019) Mario Iannaccone et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Newer Generation Ultra-Thin Strut Drug-Eluting Stents versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: A Meta-Analysis of Randomized Trials

(2018) Sripal Bangalore et al.   CIRCULATION

Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent

(2018) Thierry Lefèvre et al.   JACC-Cardiovascular Interventions

A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial

(2018) Robbert J de Winter et al.   LANCET

Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial)

(2018) Lisette Jensen et al.   EuroIntervention

Impact of diabetes on clinical outcomes after revascularization with sirolimus-eluting and biolimus-eluting stents with biodegradable polymer from the SORT OUT VII trial

(2018) Julia Ellert et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

2018 ESC/EACTS Guidelines on myocardial revascularization

(2018) Franz-Josef Neumann et al.   EUROPEAN HEART JOURNAL

Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial

(2018) Thomas Pilgrim et al.   LANCET

Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial

(2018) Clemens von Birgelen et al.   LANCET

Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial

(2018) Marlies M. Kok et al.   EuroIntervention

Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial

(2018) Christoph J. Jensen et al.   EuroIntervention

From bare metal to barely anything: an update on coronary stenting

(2017) Raffaele Piccolo et al.   HEART

Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions

(2017) Koen Teeuwen et al.   JACC-Cardiovascular Interventions

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial

(2017) David E Kandzari et al.   LANCET

Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention

(2016) Lisette Okkels Jensen et al.   Circulation-Cardiovascular Interventions

The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence

(2016) Alberto Chisari et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction

(2016) Raffaele Piccolo et al.   JACC-Cardiovascular Interventions

Percutaneous Coronary Interventions for the Treatment of Stenoses in Small Coronary Arteries

(2016) George C.M. Siontis et al.   JACC-Cardiovascular Interventions

Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents

(2016) Sebastian Kufner et al.   JACC-Cardiovascular Interventions

Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial

(2016) Clemens von Birgelen et al.   LANCET

Clinical outcomes in 995 unselected real-world patients treated with an ultrathin biodegradable polymer-coated sirolimus-eluting stent: 12-month results from the FLEX Registry

(2016) Pedro A Lemos et al.   BMJ Open

Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: Results of the Randomized BIOFLOW-II Trial

(2015) S. Windecker et al.   Circulation-Cardiovascular Interventions

Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease

(2015) Raffaele Piccolo et al.   JACC-Cardiovascular Interventions

Stable coronary artery disease: revascularisation and invasive strategies

(2015) Raffaele Piccolo et al.   LANCET

Meta-Analysis of Randomized Trials Comparing the Effectiveness of Different Strategies for the Treatment of Drug-Eluting Stent Restenosis

(2014) Raffaele Piccolo et al.   AMERICAN JOURNAL OF CARDIOLOGY

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

(2014) Thomas Pilgrim et al.   LANCET

Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents

(2013) Tomohisa Tada et al.   JACC-Cardiovascular Interventions

First-in-Human Evaluation of a Bioabsorbable Polymer–Coated Sirolimus-Eluting Stent

(2013) John Ormiston et al.   JACC-Cardiovascular Interventions

Clinical Outcomes With Bioabsorbable Polymer- Versus Durable Polymer-Based Drug-Eluting and Bare-Metal Stents

(2013) Tullio Palmerini et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study

(2013) Martial Hamon et al.   EuroIntervention

First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial

(2013) Sameer Dani et al.   EuroIntervention

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis

(2013) S. Bangalore et al.   BMJ-British Medical Journal

Polymer-Free Sirolimus- and Probucol-Eluting Versus New Generation Zotarolimus-Eluting Stents in Coronary Artery Disease

(2011) Steffen Massberg et al.   CIRCULATION

Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

(2011) Kumaran Kolandaivelu et al.   CIRCULATION

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials

(2009) Federico Piscione et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS